175 related articles for article (PubMed ID: 15892636)
1. Non-steroidal steroid receptor modulators.
Buijsman RC; Hermkens PH; van Rijn RD; Stock HT; Teerhuis NM
Curr Med Chem; 2005; 12(9):1017-75. PubMed ID: 15892636
[TBL] [Abstract][Full Text] [Related]
2. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
3. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha.
Ferguson SS; Chen Y; LeCluyse EL; Negishi M; Goldstein JA
Mol Pharmacol; 2005 Sep; 68(3):747-57. PubMed ID: 15933212
[TBL] [Abstract][Full Text] [Related]
4. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
5. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors.
Lu NZ; Wardell SE; Burnstein KL; Defranco D; Fuller PJ; Giguere V; Hochberg RB; McKay L; Renoir JM; Weigel NL; Wilson EM; McDonnell DP; Cidlowski JA
Pharmacol Rev; 2006 Dec; 58(4):782-97. PubMed ID: 17132855
[No Abstract] [Full Text] [Related]
6. Therapeutic opportunities for liver X receptor modulators.
Collins JL
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
[TBL] [Abstract][Full Text] [Related]
7. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
8. In vitro nuclear receptor inhibition and cytotoxicity of hydraulic fracturing chemicals and their binary mixtures.
Bain PA; Kumar A
Chemosphere; 2018 May; 198():565-573. PubMed ID: 29433907
[TBL] [Abstract][Full Text] [Related]
9. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of selective modulators of nuclear receptor action.
Resche-Rigon M; Gronemeyer H
Curr Opin Chem Biol; 1998 Aug; 2(4):501-7. PubMed ID: 9736923
[TBL] [Abstract][Full Text] [Related]
11. Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activity.
Trapp T; Holsboer F
J Biol Chem; 1996 Apr; 271(17):9879-82. PubMed ID: 8626619
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor profiling of vinclozolin and its primary metabolites.
Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages.
Ayaori M; Sawada S; Yonemura A; Iwamoto N; Ogura M; Tanaka N; Nakaya K; Kusuhara M; Nakamura H; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):163-8. PubMed ID: 16254209
[TBL] [Abstract][Full Text] [Related]
14. The Role of Steroid Hormone Receptors in the Establishment of Pregnancy in Rodents.
Adams NR; DeMayo FJ
Adv Anat Embryol Cell Biol; 2015; 216():27-49. PubMed ID: 26450493
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptors: doubling up in the lung.
Farrow SN
Curr Opin Pharmacol; 2008 Jun; 8(3):275-9. PubMed ID: 18343198
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
Wardell SE; Edwards DP
Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist.
Kainuma M; Makishima M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2007 Apr; 15(7):2587-600. PubMed ID: 17292610
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal steroid receptor modulators.
Hermkens PH; Kamp S; Lusher S; Veeneman GH
IDrugs; 2006 Jul; 9(7):488-94. PubMed ID: 16821162
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633).
Du X; Eksterowicz J; Zhou H; Rew Y; Zhu L; Yan X; Medina JC; Huang T; Chen X; Sutimantanapi D; Jahchan N; Kong W; Sun J; Zavorotinskaya T; Ye Q; Fantin VR; Sun D
J Med Chem; 2019 Jul; 62(14):6751-6764. PubMed ID: 31274313
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
